Literature DB >> 16935866

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.

Douglas P Zipes1, A John Camm, Martin Borggrefe, Alfred E Buxton, Bernard Chaitman, Martin Fromer, Gabriel Gregoratos, George Klein, Arthur J Moss, Robert J Myerburg, Silvia G Priori, Miguel A Quinones, Dan M Roden, Michael J Silka, Cynthia Tracy, Silvia G Priori, Jean-Jacques Blanc, Andrzej Budaj, A John Camm, Veronica Dean, Jaap W Deckers, Catherine Despres, Kenneth Dickstein, John Lekakis, Keith McGregor, Marco Metra, Joao Morais, Ady Osterspey, Juan Luis Tamargo, José Luis Zamorano, Sidney C Smith, Alice K Jacobs, Cynthia D Adams, Elliott M Antman, Jeffrey L Anderson, Sharon A Hunt, Jonathan L Halperin, Rick Nishimura, Joseph P Ornato, Richard L Page, Barbara Riegel.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16935866     DOI: 10.1093/europace/eul108

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


× No keyword cloud information.
  101 in total

1.  Identification of adenylate cyclase-coupled beta-adrenergic receptors with radiolabeled beta-adrenergic antagonists.

Authors:  R J Lefkowitz
Journal:  Biochem Pharmacol       Date:  1975-09-15       Impact factor: 5.858

2.  Is T-wave alternans testing feasible in candidates for prophylactic implantable defibrillators?

Authors:  K Kraaier; T McCracken; J van der Palen; A A M Wilde; M F Scholten
Journal:  Neth Heart J       Date:  2011-01       Impact factor: 2.380

3.  Sleep quality and sleepiness in persons with implantable cardioverter defibrillators: outcome from a clinical randomized longitudinal trial.

Authors:  Selina Kikkenborg Berg; Melinda Higgins; Carolyn M Reilly; Jonathan J Langberg; Sandra B Dunbar
Journal:  Pacing Clin Electrophysiol       Date:  2012-02-03       Impact factor: 1.976

4.  [ICD therapy as secondary prevention].

Authors:  K Seidl; M Strauss; T Kleemann
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2010-06

5.  Heart rate turbulence for prediction of heart transplantation and mortality in chronic heart failure.

Authors:  Beata Sredniawa; Sylwia Cebula; Jacek Kowalczyk; Velislav N Batchvarov; Agata Musialik-Lydka; Anna Sliwinska; Aleksandra Wozniak; Michal Zakliczynski; Marian Zembala; Zbigniew Kalarus
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-07       Impact factor: 1.468

6.  Bleeding complications after pacemaker or cardioverter-defibrillator implantation in patients receiving dual antiplatelet therapy: Results of a prospective, two-centre registry.

Authors:  A Przybylski; P Derejko; W Kwaśniewski; D Urbańczyk-Swić; J Zakrzewska; W Orszulak; M Orczykowski; A Filipecki; L Szumowski; F Walczak; M Trusz-Gluza
Journal:  Neth Heart J       Date:  2010-05       Impact factor: 2.380

7.  Rare cause of ventricular tachycardia: Pheochromocytoma.

Authors:  Joanna Delekta; Sam Riahi; Ole Eschen
Journal:  J Cardiol Cases       Date:  2014-11-14

8.  Unusual cause of syncope in young girl: arrhythmogenic right ventricular cardiomyopathy.

Authors:  Marcus Mutschelknauss; Lucas Jörg; Florian Schmid; Hans Rickli; Peter Ammann
Journal:  Clin Res Cardiol       Date:  2010-01-05       Impact factor: 5.460

9.  Guidelines for the diagnosis and management of syncope (version 2009).

Authors:  Angel Moya; Richard Sutton; Fabrizio Ammirati; Jean-Jacques Blanc; Michele Brignole; Johannes B Dahm; Jean-Claude Deharo; Jacek Gajek; Knut Gjesdal; Andrew Krahn; Martial Massin; Mauro Pepi; Thomas Pezawas; Ricardo Ruiz Granell; Francois Sarasin; Andrea Ungar; J Gert van Dijk; Edmond P Walma; Wouter Wieling
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

10.  Safe drug use in long QT syndrome and Brugada syndrome: comparison of website statistics.

Authors:  Pieter G Postema; Jon Neville; Jonas S S G de Jong; Klaus Romero; Arthur A M Wilde; Raymond L Woosley
Journal:  Europace       Date:  2013-03-26       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.